News & Trends - MedTech & Diagnostics
$6.6 million for Australian research to find answers to critical health questions
The Morrison Government is investing more than $6.6 million in four research projects that seek to answer important public health questions around melanoma detection in high-risk patients, the effectiveness of breast MRIs, the cost of chronic fatigue and mobile x-rays at residential aged care facilities.
These projects are funded under the Medical Research Future Fund’s (MRFF) $39.8 million Targeted Health System and Community Organisation Research Initiative.
The initiative is designed to address gaps in knowledge and evidence for important health system issues.
This includes the comparative effectiveness of a health service or health system practice.
The focus areas require more targeted research and have high community need but low commercial interest.
This round of funding is focused on targeted research questions and topics, put forward by the National Health Technology Assessment (NHTA) Chairs Committee that seek to examine:
- The effectiveness of Melanoma Surveillance Photography in high-risk individuals.
- When breast MRIs improve patient outcomes.
- The impact of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome on the Australian economy.
- Whether mobile x-ray units to residents of residential aged care facilities are cost effective.
Research findings will inform improvements in current practice and ultimately support better health outcomes for patients.
You may also like Eye scan sheds new light on Alzheimer’s disease
News & Trends - MedTech & Diagnostics
AI-assisted colonoscopy boosts polyp and adenoma detection
MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]
MoreNews & Trends - Pharmaceuticals
‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO
Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]
MoreNews & Trends - Pharmaceuticals
Government’s silence on Senate report leaves cancer patients in limbo
Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]
More